These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27250739)

  • 1. Urine colorimetry to detect Low rifampin exposure during tuberculosis therapy: a proof-of-concept study.
    Zentner I; Schlecht HP; Khensouvann L; Tamuhla N; Kutzler M; Ivaturi V; Pasipanodya JG; Gumbo T; Peloquin CA; Bisson GP; Vinnard C
    BMC Infect Dis; 2016 Jun; 16():242. PubMed ID: 27250739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine colorimetry for therapeutic drug monitoring of pyrazinamide during tuberculosis treatment.
    Zentner I; Modongo C; Zetola NM; Pasipanodya JG; Srivastava S; Heysell SK; Mpagama S; Schlect HP; Gumbo T; Bisson GP; Vinnard C
    Int J Infect Dis; 2018 Mar; 68():18-23. PubMed ID: 29253711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of Rifampin Concentrations by Urine Colorimetry and Mobile Phone Readout for Personalized Dosing in Tuberculosis Treatment.
    Szipszky C; Van Aartsen D; Criddle S; Rao P; Zentner I; Justine M; Mduma E; Mpagama S; Al-Shaer MH; Peloquin C; Thomas TA; Vinnard C; Heysell SK
    J Pediatric Infect Dis Soc; 2021 Mar; 10(2):104-111. PubMed ID: 32170944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine colorimetry for levofloxacin pharmacokinetics and personalized dosing in people with drug-resistant tuberculosis.
    Rao P; Zhdanova S; Ogarkov O; Orlova E; Ebers A; Stroup S; Mirawdaly S; Aartsen DV; Koshkina O; Suzdalnitsky A; Moiseeva E; Dillingham R; Heysell SK
    Int J Mycobacteriol; 2020; 9(4):411-416. PubMed ID: 33323657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of urine testing for verifying adherence to anti-tuberculosis chemotherapy in children and adults in Uganda.
    Meissner PE; Musoke P; Okwera A; Bunn JE; Coulter JB
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):903-8. PubMed ID: 12365577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring in the treatment of tuberculosis.
    Peloquin CA
    Drugs; 2002; 62(15):2169-83. PubMed ID: 12381217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic Modeling and Optimal Sampling Strategies for Therapeutic Drug Monitoring of Rifampin in Patients with Tuberculosis.
    Sturkenboom MG; Mulder LW; de Jager A; van Altena R; Aarnoutse RE; de Lange WC; Proost JH; Kosterink JG; van der Werf TS; Alffenaar JW
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4907-13. PubMed ID: 26055359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of first-line antituberculosis drugs in HIV-infected children with tuberculosis treated with intermittent regimens in India.
    Ramachandran G; Kumar AK; Bhavani PK; Kannan T; Kumar SR; Gangadevi NP; Banurekha VV; Sekar L; Ravichandran N; Mathevan G; Sanjeeva GN; Dayal R; Swaminathan S
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1162-7. PubMed ID: 25487804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to total and protein-unbound rifampin is not affected by malnutrition in Indonesian tuberculosis patients.
    te Brake LH; Ruslami R; Later-Nijland H; Mooren F; Teulen M; Apriani L; Koenderink JB; Russel FG; Burger DM; Alisjahbana B; Wieringa F; van Crevel R; Aarnoutse RE
    Antimicrob Agents Chemother; 2015; 59(6):3233-9. PubMed ID: 25801554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
    Verbeeck RK; Günther G; Kibuule D; Hunter C; Rennie TW
    Eur J Clin Pharmacol; 2016 Aug; 72(8):905-16. PubMed ID: 27305904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Accuracy of Therapeutic Drug Monitoring During Tuberculosis Treatment.
    Anderson G; Vinnard C
    J Clin Pharmacol; 2022 Oct; 62(10):1206-1214. PubMed ID: 35588142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Serum Concentrations of Rifampicin and Pyrazinamide Associated with Poor Treatment Outcomes in Children with Tuberculosis Related to HIV Status.
    Ramachandran G; Kumar AK; Kannan T; Bhavani PK; Kumar SR; Gangadevi NP; Banurekha VV; Sudha V; Venkatesh S; Ravichandran N; Kalpana S; Mathevan G; Sanjeeva GN; Agarwal D; Swaminathan S
    Pediatr Infect Dis J; 2016 May; 35(5):530-4. PubMed ID: 26825153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin.
    van Beek SW; Ter Heine R; Keizer RJ; Magis-Escurra C; Aarnoutse RE; Svensson EM
    Clin Pharmacokinet; 2019 Jun; 58(6):815-826. PubMed ID: 30671890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of dried blood spot sampling for pharmacokinetic research and therapeutic drug monitoring of anti-tuberculosis drugs in children.
    Martial LC; Kerkhoff J; Martinez N; Rodríguez M; Coronel R; Molinas G; Roman M; Gomez R; Aguirre S; Jongedijk E; Huisman J; Touw DJ; Pérez D; Chaparro G; Gonzalez F; Aarnoutse RE; Alffenaar JW; Magis-Escurra C
    Int J Antimicrob Agents; 2018 Jul; 52(1):109-113. PubMed ID: 29751121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis Patients.
    van den Elsen SHJ; Sturkenboom MGG; Akkerman OW; Manika K; Kioumis IP; van der Werf TS; Johnson JL; Peloquin C; Touw DJ; Alffenaar JC
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of thrice-weekly rifampicin, isoniazid and pyrazinamide in adult tuberculosis patients in India.
    Hemanth Kumar AK; Kannan T; Chandrasekaran V; Sudha V; Vijayakumar A; Ramesh K; Lavanya J; Swaminathan S; Ramachandran G
    Int J Tuberc Lung Dis; 2016 Sep; 20(9):1236-41. PubMed ID: 27510252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosis.
    Perlman DC; Segal Y; Rosenkranz S; Rainey PM; Remmel RP; Salomon N; Hafner R; Peloquin CA;
    Clin Infect Dis; 2005 Dec; 41(11):1638-47. PubMed ID: 16267738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cure of tuberculosis despite serum concentrations of antituberculosis drugs below published reference ranges.
    Meloni M; Corti N; Müller D; Henning L; Gutteck U; von Braun A; Weber R; Fehr J
    Swiss Med Wkly; 2015; 145():w14223. PubMed ID: 26700218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine levels of rifampicin & isoniazid in asymptomatic HIV-positive individuals.
    Ramachandran G; Hemanth Kumar AK; Sarala K; Padmapriyadarsini C; Anitha S; Tharani CB; Kumaraswami V; Swaminathan S
    Indian J Med Res; 2007 Jun; 125(6):763-6. PubMed ID: 17704553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of rifampicin in Mexican patients with tuberculosis and healthy volunteers.
    Medellín-Garibay SE; Milán-Segovia Rdel C; Magaña-Aquino M; Portales-Pérez DP; Romano-Moreno S
    J Pharm Pharmacol; 2014 Oct; 66(10):1421-8. PubMed ID: 24841364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.